tiprankstipranks
Spyre Therapeutics (SYRE)
NASDAQ:SYRE
US Market
Holding SYRE?
Track your performance easily

Spyre Therapeutics (SYRE) Technical Analysis

421 Followers

Technical Sentiment

Overall Consensus
Buy
11Bullish
6Neutral
5Bearish
Technical Analysis Consensus
Buy
3Bullish
6Neutral
1Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
Spyre Therapeutics’s (SYRE) Moving Averages Convergence Divergence (MACD) indicator is 2.02, suggesting Spyre Therapeutics is a Sell.
Spyre Therapeutics’s (SYRE) 20-Day exponential moving average is 34.87, while Spyre Therapeutics’s (SYRE) share price is $35.82, making it a Buy.
Spyre Therapeutics’s (SYRE) 50-Day exponential moving average is 32.20, while Spyre Therapeutics’s (SYRE) share price is $35.82, making it a Buy.

Spyre Therapeutics (SYRE) Pivot Points

Nov 23, 2024, 07:51 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
37.13
37.87
38.61
39.35
40.09
40.83
41.57
Fibonacci
37.87
38.44
38.78
39.35
39.92
40.26
40.83
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Spyre Therapeutics (SYRE) Moving Averages

Nov 23, 2024, 07:51 AM
Period
Simple
Exponential
MA5
37.98Sell
37.31Sell
MA10
36.16Sell
36.49Sell
MA20
34.82Buy
34.87Buy
MA50
31.16Buy
32.20Buy
MA100
29.09Buy
30.70Buy
MA200
31.16Buy
29.49Buy
Spyre Therapeutics’s (SYRE) 10-Day exponential moving average is 36.49, while Spyre Therapeutics’s (SYRE) share price is $35.82, making it a Sell.
Spyre Therapeutics’s (SYRE) 100-Day exponential moving average is 30.70, while Spyre Therapeutics’s (SYRE) share price is $35.82, making it a Buy.
Spyre Therapeutics’s (SYRE) stock price is $35.82 and Spyre Therapeutics’s (SYRE) 50-day simple moving average is 31.16, creating a Buy signal.
Spyre Therapeutics’s (SYRE) stock price is $35.82 and Spyre Therapeutics’s (SYRE) 100-day simple moving average is 29.09, creating a Buy signal.
Spyre Therapeutics’s (SYRE) stock price is $35.82 and Spyre Therapeutics’s (SYRE) 200-day simple moving average is 31.16, creating a Buy signal.

Spyre Therapeutics (SYRE) Technical Indicators

Nov 23, 2024, 07:51 AM
Name
Value
Implied Action
RSI (14)
56.57
Neutral
STOCH (9,6)
78.25
Neutral
STOCHRSI (14)
78.25
Neutral
MACD (12,26)
2.02
Sell
ADX (14)
25.27
Neutral
Williams %R
-55.19
Buy
CCI (14)
97.39
Neutral
ATR (14)
2.32
-
Ultimate Oscillator
60.91
Neutral
ROC
6.58
Buy
Spyre Therapeutics’s (SYRE) Relative Strength Index (RSI) is 56.57, creating a Neutral signal.
Spyre Therapeutics’s (SYRE) Trend Strength Indicator (ADX) is 25.27, creating a Neutral signal.
Spyre Therapeutics’s (SYRE) Commodity Channel Index (CCI) is 97.39, creating a Neutral signal.
Spyre Therapeutics’s (SYRE) Price Rate of Change (ROC) is 6.58, creating a Buy signal.

FAQ

Is SYRE a Buy, Hold, or Sell?
Based on SYRE’s technical indicators, SYRE is a Buy.
    What is SYRE’s RSI (14)?
    SYRE’s RSI (14) is 56.57, which suggests SYRE is a Neutral.
      What is SYRE’s MACD?
      SYRE’s MACD is 2.02, which suggests SYRE is a Sell.
        What is SYRE’s 5-day moving average?
        SYRE’s 5-day moving average is 37.98, which suggests SYRE is a Sell.
          What is SYRE’s 20-day moving average?
          SYRE 20-day moving average is 34.82, which suggests SYRE is a Buy.
            What is SYRE’s 50-day moving average?
            SYRE’s 50-day moving average is 31.16, which suggests SYRE is a Buy.
              What is SYRE’s 200-day moving average?
              SYRE’s 200-day moving average is 31.16, which suggests SYRE is a Buy.
                What is SYRE’s Williams % R (14)?
                SYRE’s Williams % R (14) is -55.19, which suggests SYRE is a Buy.
                  What is SYRE’s CCI (14)?
                  SYRE’s CCI (14) is 97.39, which suggests SYRE is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis